PTJ
CAI

Paul Tudor Jones’s Caris Life Sciences CAI Stock Holding History

Paul Tudor Jones’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Hold
100,327
– – ﹤0.01% 2017
2026
Q1 		$1.79M Sell
100,327
-82,055
-45% -$1.79M ﹤0.01% 1923
2025
Q4 		$4.92M Sell
182,382
-82,169
-31% -$2.31M 0.01% 1161
2025
Q3 		$8M Hold
264,551
– – 0.01% 895
2025
Q2 		$7.07M Buy
+264,551
New +$7.13M 0.02% 877

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Paul Tudor Jones's CAI Position: Q2 2026 in Review

Paul Tudor Jones held its Caris Life Sciences (CAI) position steady in Q2 2026 at 100,327 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.

Paul Tudor Jones first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $8M in Q3 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Paul Tudor Jones held 100,327 shares of Caris Life Sciences worth $1.79M as of Q2 2026.
  • Paul Tudor Jones left its Caris Life Sciences share count unchanged in Q2 2026.
  • Caris Life Sciences made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2017 holding.
  • Paul Tudor Jones first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Paul Tudor Jones's Caris Life Sciences position peaked at $8M in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.